TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 30,024,840 | 25,090,674 | 25,158,213 |
Financial expenses | 35,380 | 212,062 | 10,617 |
Earnings before taxes | 5,385,096 | 4,719,233 | 4,135,663 |
EBITDA | 6,854,481 | 6,336,517 | 5,469,713 |
Total assets | 44,560,567 | 38,725,095 | 35,880,157 |
Current assets | 31,870,450 | 27,137,720 | 25,285,512 |
Current liabilities | 4,199,969 | 3,907,272 | 3,252,849 |
Equity capital | 38,096,082 | 32,903,498 | 30,607,733 |
- share capital | 1,263 | 1,200 | 1,051 |
Employees (average) | 9,734 | 8,336 | 8,141 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 85.5% | 85.0% | 85.3% |
Turnover per employee | 3,085 | 3,010 | 3,090 |
Profit as a percentage of turnover | 17.9% | 18.8% | 16.4% |
Return on assets (ROA) | 12.2% | 12.7% | 11.6% |
Current ratio | 758.8% | 694.5% | 777.3% |
Return on equity (ROE) | 14.1% | 14.3% | 13.5% |
Change turnover | 5,688,247 | 1,670,654 | 927,028 |
Change turnover % | 23% | 7% | 4% |
Chg. No. of employees | 1,398 | 195 | 233 |
Chg. No. of employees % | 17% | 2% | 3% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.